Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine

Biochem J. 1994 Dec 1;304 ( Pt 2)(Pt 2):477-83. doi: 10.1042/bj3040477.

Abstract

In in vitro systems haem oxygenase-1 (HO-1) mRNA increases after exposure to agents causing oxidative stress. We lowered cellular antioxidant defence systems in vivo by giving mice increasing doses (0.15 g/kg-1.6 g/kg) of DL-buthionine-(S,R)-sulphoximine (BSO), a specific inhibitor of glutathione synthesis. Maximum glutathione depletion (80%) coincided with maximum hepatic HO-1 mRNA accumulation (about 20 times), whereas with 50% depletion, accumulation was only doubled. It has been suggested that reactive oxygen and nitrogen intermediates are involved in hepatic toxicity of endotoxin (lipopolysaccharide, LPS); LPS even at low doses [0.1 mg/kg, intraperitoneally (i.p.)] induces HO-1 mRNA about 25-fold after 1 h. Hepatic glutathione depletion (respectively 40% and 80%) after a low (0.3 g/kg) or a high (1.6 g/kg) BSO dose, resulted in potentiation of the HO-1 mRNA accumulation induced by LPS (0.1 mg/kg, i.p.). In the absence of BSO, N-acetylcysteine (NAC) (1 g/kg orally) reduced LPS-induced HO-1 mRNA accumulation to one fourth. Under the same experimental conditions S-adenosylmethionine (SAM) was not effective. NAC also reduced HO-1 mRNA accumulation when administered to mice in which glutathione was depleted and its synthesis blocked by BSO (1.6 g/kg). Thus reactive oxygen intermediates are likely mediators of LPS-induced HO-1 mRNA accumulation, and glutathione content appears to be one of the factors regulating this accumulation in the liver. Our findings are compatible with the theory that HO-1 induction might have a protective function in vivo when defence mechanisms against oxidants are challenged.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology*
  • Animals
  • Buthionine Sulfoximine
  • Dose-Response Relationship, Drug
  • Escherichia coli
  • Glutathione / antagonists & inhibitors
  • Glutathione / metabolism*
  • Heme Oxygenase (Decyclizing) / genetics*
  • Lipopolysaccharides / pharmacology*
  • Liver / drug effects
  • Liver / enzymology*
  • Male
  • Methionine Sulfoximine / administration & dosage
  • Methionine Sulfoximine / analogs & derivatives
  • Methionine Sulfoximine / pharmacology
  • Mice
  • Oxidative Stress
  • RNA, Messenger / metabolism*
  • S-Adenosylmethionine / pharmacology

Substances

  • Lipopolysaccharides
  • RNA, Messenger
  • Methionine Sulfoximine
  • Buthionine Sulfoximine
  • S-Adenosylmethionine
  • Heme Oxygenase (Decyclizing)
  • Glutathione
  • Acetylcysteine